BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 25399911)

  • 1. Therapeutic face of RNAi: in vivo challenges.
    Borna H; Imani S; Iman M; Azimzadeh Jamalkandi S
    Expert Opin Biol Ther; 2015 Feb; 15(2):269-85. PubMed ID: 25399911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference as a gene-specific approach for molecular medicine.
    Grünweller A; Hartmann RK
    Curr Med Chem; 2005; 12(26):3143-61. PubMed ID: 16375707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Journey of siRNA: Clinical Developments and Targeted Delivery.
    Nikam RR; Gore KR
    Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA, miRNA, and shRNA: in vivo applications.
    Pushparaj PN; Aarthi JJ; Manikandan J; Kumar SD
    J Dent Res; 2008 Nov; 87(11):992-1003. PubMed ID: 18946005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo gene silencing following non-invasive siRNA delivery into the skin using a novel topical formulation.
    Hegde V; Hickerson RP; Nainamalai S; Campbell PA; Smith FJ; McLean WH; Pedrioli DM
    J Control Release; 2014 Dec; 196():355-62. PubMed ID: 25449884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
    Bolhassani A; Milani A
    Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery systems of small interfering RNA by systemic administration.
    Kawakami S; Hashida M
    Drug Metab Pharmacokinet; 2007 Jun; 22(3):142-51. PubMed ID: 17603214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA delivery systems for cancer treatment.
    Oh YK; Park TG
    Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short interfering RNA (siRNA): tool or therapeutic?
    Cejka D; Losert D; Wacheck V
    Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene silencing mediated by small interfering RNAs in mammalian cells.
    Scherr M; Morgan MA; Eder M
    Curr Med Chem; 2003 Feb; 10(3):245-56. PubMed ID: 12570711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycation-based nanoparticle delivery for improved RNA interference therapeutics.
    Howard KA; Kjems J
    Expert Opin Biol Ther; 2007 Dec; 7(12):1811-22. PubMed ID: 18034647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
    Liu B
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK; Hajeri PB
    Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knocking down disease with siRNAs.
    Dykxhoorn DM; Lieberman J
    Cell; 2006 Jul; 126(2):231-5. PubMed ID: 16873051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAi-based drug discovery and its application to therapeutics.
    Hokaiwado N; Takeshita F; Banas A; Ochiya T
    IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of small RNA using lipid nanoparticles.
    Asai T; Oku N
    Biol Pharm Bull; 2014; 37(2):201-5. PubMed ID: 24492716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.